T
Topaz Pharmaceuticals
Innovative pharmaceutical solutions enhancing patient care and health outcomes
About Topaz Pharmaceuticals
Topaz Pharma is a dynamic player in the pharmaceutical industry, dedicated to improving patient care and health outcomes through innovative solutions. The company operates in the healthcare market, serving a diverse clientele that includes hospitals, clinics, and individual patients. Topaz Pharma's business model revolves around the development, manufacturing, and distribution of high-quality pharmaceutical products. Revenue is generated through the sale of these products to healthcare providers and directly to consumers. The company focuses on research and development to bring new and effective treatments to market, ensuring they meet the highest standards of safety and efficacy. Topaz Pharma's commitment to quality and innovation positions it as a trusted partner in the healthcare sector.
Source: Dealroom company dataAt a glance
- Founded
- 2005
- Headquarters
- United States
- Sector
- Edtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Aisling Capital
F-Prime
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Topaz Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Topaz Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.